Clinical Trial Update: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of HuHuangLianzonggan Capsule for nonalcoholic steatohepatitis is currently recruiting, sponsored by Tasly Pharmaceutical Group Co., Lt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• HuHuangLianzonggan Capsule

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: NASH | Phase 2 | Status: RECRUITING